​

United Therapeutics Ownership | Who Owns United Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

United Therapeutics Ownership Summary

United Therapeutics is owned by 89.35% institutional investors, 1.85% insiders, and 8.80% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 11.87% of UTHR shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.25% of its assets in United Therapeutics shares.

UTHR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockUnited Therapeutics89.35%1.85%8.80%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.35M11.87%$2.24B
Blackrock5.47M11.64%$1.74B
Vanguard group4.42M9.80%$1.85B
Renaissance2.17M4.82%$911.11M
Avoro capital advisors2.02M4.48%$847.74M
State street1.92M4.26%$805.98M
Wellington management group llp1.40M3.10%$586.38M
Geode capital management1.25M2.77%$522.91M
Aqr capital management975.44K2.19%$344.18M
Darwin global management748.55K1.66%$317.62M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management97.65K17.44%$40.93M
Tri locum partners lp122.19K11.77%$51.22M
Avoro capital advisors2.02M10.96%$847.74M
Darwin global management748.55K8.83%$317.62M
Eversept partners, lp253.22K7.32%$106.15M
Nepsis44.42K5.90%$18.62M
First turn management85.32K5.37%$35.77M
Palo alto investors lp58.19K4.51%$24.39M
Sofinnova investments190.63K4.37%$79.91M
Poplar forest capital59.88K3.89%$21.13M

Top Buyers

HolderShares% AssetsChange
Darwin global management748.55K8.83%748.55K
Citigroup551.47K0.10%508.94K
Norges bank430.12K0.02%430.12K
Eversept partners, lp253.22K7.32%193.85K
Price t rowe associates inc /md/300.93K0.01%186.43K

Top Sellers

HolderShares% AssetsChange
Citadel advisors---719.31K
Caisse de depot et placement du quebec98.14K0.07%-384.64K
Avoro capital advisors2.02M10.96%-347.78K
Vaughan nelson investment management---328.78K
Victory capital management109.75K0.03%-286.90K

New Positions

HolderShares% AssetsChangeValue
Darwin global management748.55K8.83%748.55K$317.62M
Norges bank430.12K0.02%430.12K$151.76M
Tri locum partners lp122.19K11.77%122.19K$51.22M
Orbimed advisors114.90K1.14%114.90K$48.17M
Point72 asset management99.78K0.07%99.78K$41.83M

Sold Out

HolderChange
Financial synergies wealth advisors-1.00
Financial gravity asset management-1.00
Raleigh capital management-1.00
Opal wealth advisors-2.00
Cva family office-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20257085.20%40,294,923-2.97%891.05%319-10.64%26425.71%
Jun 30, 20256810.59%43,719,199-1.26%961.00%3584.99%214-4.89%
Mar 31, 2025670-2.33%43,709,344-0.77%971.00%338-9.38%2236.70%
Dec 31, 2024628-1.10%59,260,45237.20%1321.42%3408.63%191-15.49%
Sep 30, 20246267.56%43,411,015-5.14%971.03%3080.65%22315.54%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Mid-Cap ETF1.47M3.25%-
Vanguard US Total Market Shares ETF1.41M3.14%1.06K
Vanguard Total Stock Mkt Idx Inv1.42M3.13%-29.92K
Vanguard Small Cap Index1.10M2.42%-7.03K
Vanguard Health Care Inv910.86K2.01%-
Vanguard Small Cap Value Index Inv704.76K1.56%1.50K
Vanguard Windsor Investor Shares488.35K1.09%-40.43K
Vanguard Institutional Extnd Mkt Idx Tr485.01K1.07%-209.76K
SPDR® S&P Biotech ETF424.26K0.94%945.00
Invesco S&P MidCap Quality ETF400.05K0.88%83.00

Recent Insider Transactions

DateNameRoleActivityValue
Nov 28, 2025ROTHBLATT MARTINE A Chairperson & CEOSell$784.06K
Nov 28, 2025ROTHBLATT MARTINE A Chairperson & CEOSell$532.80K
Nov 28, 2025ROTHBLATT MARTINE A Chairperson & CEOSell$388.57K
Nov 26, 2025ROTHBLATT MARTINE A Chairperson & CEOSell$1.03M
Nov 26, 2025ROTHBLATT MARTINE A Chairperson & CEOSell$662.84K

Insider Transactions Trends

DateBuySell
2025 Q4-237
2025 Q3-150
2025 Q2-61
2025 Q1-145
2024 Q4-174

UTHR Ownership FAQ

Who Owns United Therapeutics?

United Therapeutics shareholders are primarily institutional investors at 89.35%, followed by 1.85% insiders and 8.80% retail investors. The average institutional ownership in United Therapeutics's industry, Biotech Stocks , is 45.24%, which United Therapeutics exceeds.

Who owns the most shares of United Therapeutics?

United Therapeutics’s largest shareholders are Blackrock funding, inc. /de (5.35M shares, 11.87%), Blackrock (5.47M shares, 11.64%), and Vanguard group (4.42M shares, 9.80%). Together, they hold 33.30% of United Therapeutics’s total shares outstanding.

Does Blackrock own United Therapeutics?

Yes, BlackRock owns 11.64% of United Therapeutics, totaling 5.47M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.74B$. In the last quarter, BlackRock decreased its holdings by -98.516K shares, a -1.77% change.

Who is United Therapeutics’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is United Therapeutics’s biggest shareholder by percentage of total assets invested, with 17.44% of its assets in 97.65K United Therapeutics shares, valued at 40.93M$.

Who is the top mutual fund holder of United Therapeutics shares?

iShares Core S&P Mid-Cap ETF is the top mutual fund holder of United Therapeutics shares, with 3.25% of its total shares outstanding invested in 1.47M United Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools